0000876661-23-000363.txt : 20230426
0000876661-23-000363.hdr.sgml : 20230426
20230426101255
ACCESSION NUMBER: 0000876661-23-000363
CONFORMED SUBMISSION TYPE: 25-NSE
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20230426
DATE AS OF CHANGE: 20230426
EFFECTIVENESS DATE: 20230426
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: GELESIS HOLDINGS, INC.
CENTRAL INDEX KEY: 0001805087
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 844730610
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39362
FILM NUMBER: 23847342
BUSINESS ADDRESS:
STREET 1: 501 BOYLSTON STREET, SUITE 6102
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 857-327-7737
MAIL ADDRESS:
STREET 1: 501 BOYLSTON STREET, SUITE 6102
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: CAPSTAR SPECIAL PURPOSE ACQUISITION CORP.
DATE OF NAME CHANGE: 20200227
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NEW YORK STOCK EXCHANGE LLC
CENTRAL INDEX KEY: 0000876661
IRS NUMBER: 000000000
STATE OF INCORPORATION: NY
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
BUSINESS PHONE: 212-656-2060
MAIL ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
FORMER COMPANY:
FORMER CONFORMED NAME: NEW YORK STOCK EXCHANGE INC
DATE OF NAME CHANGE: 19910628
25-NSE
1
primary_doc.xml
X0203
0000876661
NEW YORK STOCK EXCHANGE LLC
0001805087
GELESIS HOLDINGS, INC.
001-39362
501 Boylston Street Suite 6102
Boston
MA
MASSACHUSETTS
02116
857-327-7737
Common Stock
17 CFR 240.12d2-2(b)
Christopher Rances
Senior Analyst, Market Watch and Proxy Compliance
2023-04-26
EX-99.25
2
ruleprovisionnotice.htm
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES
The New York Stock Exchange ("NYSE" or the "Exchange") hereby notifies the Securities and Exchange Commission (the "Commission") of its intention to remove the entire class of Common Stock (the "Common Stock") of Gelesis Holdings, Inc. (the "Company") from listing and registration on the Exchange on May 8, 2023, pursuant to the provisions of Rule 12d2-2(b) because, in the opinion of the Exchange, the Common Stock are no longer suitable for continued listing and trading on the NYSE.
The Exchange has determined that the Common Stock is no longer suitable for listing, pursuant to Section 802.01B of the NYSE's Listed Company Manual, because the Company had fallen below the NYSE's continued listing standard requiring listed companies to maintain an average global market capitalization over a consecutive 30 trading day period of at least $15,000,000.
On April 10, 2023, the Exchange determined that the Common Stock of the Company should be suspended from trading and directed the preparation and filing with the Commission of this application for the removal of the Common Stock from listing and registration on the NYSE. The Company was notified on April 10, 2023.
Pursuant to the above authorization, a press release regarding the proposed delisting was issued and posted on the Exchange's website on April 10, 2023, and trading in the Common Stock was immediately suspended.
The Company had a right to appeal to a Committee of the Board of Directors of the Exchange, the determination to delist the Common Stock, provided it filed a written request for such a review with the Secretary of the Exchange within ten business days of receiving notice of the delisting determination. The Company did not file such request within the specified period. Consequently, all conditions precedent under SEC Rule 12d2-2(b) to the filing of this application have been satisfied.